Mangoceuticals (MGRX) Receivables - Other (2025 - 2026)

Mangoceuticals (MGRX) posted Receivables - Other of $20056.0 for Q1 2026, little changed sequentially from $20056.0 in Q4 2025.

Mangoceuticals (MGRX) Receivables - Other (2025 - 2026) Analysis & Trends

Mangoceuticals has reported Receivables - Other for 2 years, with the latest figure at $20056.0 in Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to $20056.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20056.0 (changed N/A YoY) and the FY2025 annual result came in at $20056.0, changed N/A from the prior year.
Receivables - Other held at $20056.0 in Q1 2026 per MGRX's latest filing, from $20056.0 in the prior quarter.
Over five years, Receivables - Other peaked at $20056.0 in Q4 2025 and troughed at $20056.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	Mangoceuticals	9.55 Mn	9.30 Mn	44,215.00

Download Data